Rhythm Pharmaceuticals, Inc. (RYTM): Insider Trading, Congress Trades & Research | Tormere

RYTM

$92.83-0.62%website ↗⬇ financials (.py)

RHYTHM PHARMACEUTICALS, INC.

Market Cap

$6.4B

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.98

60mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

26.5

Price / TTM revenue

P/B

61.8

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

23 analysts

Velocity Score

125.13x

Sell Rate (90d)

3282.78/mo

Sell Baseline

74.33/mo

Unique Sellers (90d)

7

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-14	2026-09-14	Meeker David P	Director & President and CEO	Sale	50.0K	$102.67	$5.13M	239.3K	View
2026-08-31	2026-09-01	Smith Hunter C	Chief Financial Officer	Sale	62.8K	$105.46	$6.62M	114.0K	View
2026-08-13	2026-08-17	Garfield Alastair	Chief Scientific Officer	Sale	7,763	$117.57	$913K	2,295	View
2026-08-13	2026-08-17	Shulman Joseph	Chief Technical Officer	Sale	5,079	$119.75	$608K	15.9K	View
2026-08-13	2026-08-14	Lee Jennifer Kayden	EVP, Head of North America	Sale	75.8K	$117.38	$8.90M	0	View

1–5 of 11

1 / 3

Reporting Insiders

Recent News

Why (RYTM) Price Action Is Critical for Tactical Trading

news.stocktradersdaily.com · 2026-10-03

Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity

Yahoo · 2026-09-22

Canada approves first targeted treatment for obesity caused by brain injury

Stock Titan · 2026-09-22

Rhythm Pharmaceuticals Receives Health Canada Approval Of IMCIVREE For Additional Indication Of Weight Management In Adult And Pediatric Patients 4 Years Of Age And Older With Acquired Hypothalamic Obesity

Benzinga · 2026-09-22

Ultragenyx (RARE) Surges 12.6%: Is This an Indication of Further Gains?

Yahoo · 2026-09-18

Wolfe Research Initiates Rhythm Pharmaceuticals at Outperform

Yahoo Finance · 2026-09-17

Tracking Baker Brothers' Portfolio: Q2 2026 Update

SeekingAlpha · 2026-09-16

Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

SeekingAlpha · 2026-09-15

10 Health Care Stocks With Whale Alerts In Today’s Session

Benzinga · 2026-09-11

Billionaire Stanley Druckenmiller’s 2 New Healthcare Stock Picks

Yahoo · 2026-09-11

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Yahoo · 2026-09-10

Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run

Yahoo Finance · 2026-08-26

Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can

Yahoo Finance · 2026-08-23

Rhythm Pharmaceuticals (RYTM) Stock Looks Pricey Following Strong IMCIVREE News

Simply Wall Street · 2026-08-17

Rhythm Pharmaceuticals Eyes AHO Growth, Global IMCIVREE Expansion and Pipeline Catalysts

Yahoo Finance · 2026-08-17

Informational purposes only, not investment advice.

Recent Insider Activity (Form 4) — Last 5

Date	Insider	Type	Shares	Value
2026-09-14	Meeker David P	S	30,746	$3M
2026-09-14	Meeker David P	S	6,439	$655,145.07
2026-09-14	Meeker David P	S	2,300	$241,937
2026-09-14	Meeker David P	S	1,817	$189,964.99
2026-09-14	Meeker David P	S	8,698	$899,634.14